12:00 AM
 | 
Jan 16, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

EV71 vaccine: Phase III started

Sinovac began a double-blind, placebo-controlled, Chinese Phase III trial to evaluate 2 doses of 400U EV71 plus an aluminum adjuvant given 28 days...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >